Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China flag China · Delayed Price · Currency is CNY
14.46
+0.05 (0.35%)
Feb 24, 2026, 3:00 PM CST
Market Cap8.19B +8.8%
Revenue (ttm)3.13B -30.0%
Net Income281.38M -33.8%
EPS0.49 -33.7%
Shares Out566.16M
PE Ratio29.46
Forward PE18.90
Dividendn/a
Ex-Dividend Daten/a
Volume3,824,680
Average Volume7,735,850
Open14.52
Previous Close14.41
Day's Range14.40 - 14.55
52-Week Range11.95 - 20.20
Beta0.63
RSI44.11
Earnings DateApr 23, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1975
Employees 6,132
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600557
Full Company Profile

Financial Performance

In 2024, SHA:600557's revenue was 3.90 billion, a decrease of -19.86% compared to the previous year's 4.86 billion. Earnings were 391.86 million, a decrease of -15.58%.

Financial Statements